Walleye Capital LLC Emergent Bio Solutions Inc. Transaction History

Walleye Capital LLC

$38.9 Billion
Q4 2024

A detailed history of Walleye Capital LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 28,400 shares of EBS stock, worth $156,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,400

Previous 2,000 1320.0%

Holding current value

$156,484

Previous $16,000 1593.75%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$7.72 - $11.97 $141,005 - $218,632	-18,265 Reduced 75.29%	5,993 $57,000
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $413,836 - $1.07 Million	-72,349 Reduced 74.89%	24,258 $202,000
Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $122,029 - $457,936	65,607 Added 211.64%	96,607 $658,000
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $358,035 - $813,932	-238,690 Reduced 88.51%	31,000 $78,000
Q4 2023 Feb 14, 2024	BUY	$1.82 - $3.16 $414,224 - $719,203	227,596 Added 540.69%	269,690 $647,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $451,420 - $1.13 Million	-142,404 Reduced 77.18%	42,094 $143,000
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $558,019 - $1 Million	75,921 Added 69.92%	184,498 $1.36 Million
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $199,229 - $416,616	25,575 Added 30.81%	108,577 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $853,281 - $1.66 Million	77,571 Added 1428.3%	83,002 $980,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $167,590 - $298,643	-8,342 Reduced 60.57%	5,431 $114,000
Q2 2022 Aug 08, 2022	BUY	$27.42 - $43.63 $377,655 - $600,915	13,773 New	13,773 $428,000
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $352,993 - $465,652	-7,050 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $399,100 - $567,243	7,050 New	7,050 $444,000
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $166,152 - $227,921	-3,445 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $179,312 - $229,126	3,445 New	3,445 $227,000

Others Institutions Holding EBS

# of Institutions

174

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $275M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Emergent Bio Solutions Inc. Transaction History